Myriad Genetics, Inc. (MYGN)
4.29
+0.20
(+4.89%)
USD |
NASDAQ |
May 08, 16:00
4.285
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Profit Margin (Quarterly) : -17.02% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -524.6K% |
| Plus Therapeutics, Inc. | -417.9% |
| Perspective Therapeutics, Inc. | -87.19K% |
| Atossa Therapeutics, Inc. | -- |
| AVITA Medical, Inc. | -65.97% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -92.09% |
| Return on Assets | -52.73% |
| Return on Invested Capital | -64.15% |
| Gross Profit Margin (Quarterly) | 64.72% |
| Operating Margin (Quarterly) | -12.62% |
| Return on Net Operating Assets | -66.31% |